Angiodroid

30/10/2025

30/10/2025

29/10/2025

Nurturing Growth, Ensuring Stability.

From optimizing processes to supporting people — ensuring compliance, managing resources, and building talent — they keep the structure solid, reliably, every single day.

This is a glimpse into the world of our HR & Finance team. The ones who balance our growth and sustain our mission 📈🤝

22/10/2025

🎙 Interview with Prof. med. Sabine Steiner – Universitätsklinikum AKH Wien

Discover of our interview series with Prof. med. Sabine Steiner, Principal Investigator of the study.

Prof. Steiner shares the motivation behind this essential research: exploring CO₂ Angiography as the contrast-free option of the future and protecting patients at high risk.

She highlights the urgent challenge of treating frail, older patients with restricted kidney function (GFR 30-60 ml/min) and explains why balancing complex interventions with renal protection is now an absolute priority.

🔹 The CO₂ Advantage, Confirmed:
The interview confirms CO₂ Angiography is a valid and promising alternative. While requiring some initial technical skill, participating centres have been “surprised by the great image quality” achieved in many patients. This potential positions CO₂ to “become routine” and define the new standard of care.

➡️ Watch the video to hear Prof. Steiner discuss the clinical vision and expectations behind the trial.

20/10/2025

From Vision. To Voice.

From crafting the perfect story to ensuring our message lands clearly across every channel, they keep the narrative flowing — strategically, consistently, every single day.

This is a glimpse into the world of our & team.
The ones who shape our perception and broadcast our mission globally 🌍📢

17/10/2025

🎨 The Art of Transforming Vision into Story.

They organize the experience, shape the message, and ensure its dissemination: from the seamless logistics of training courses to the lasting impression left at every congress, from the design that captures attention to the strategies that generate engagement on social media.

They listen to the market, interpret trends, and weave the narrative that connects clinical practice, safety, and innovation.

They believe that protecting kidney function isn’t just a clinical goal, but a responsibility that must be communicated clearly and persuasively.

That CO₂ isn't just a tool, but a revolution that must be told. And that this message deserves to be elevated, understood, and embraced by everyone.

This is our Team.
They are not just Angiodroid's megaphone, but its architects of perception, the strategic energy that shapes our core belief and connects it with the world.

15/10/2025

🎙 Interview with Prof. med. Sabine Steiner – Universitätsklinikum AKH Wien

In this interview, Prof. med. Sabine Steiner, Principal Investigator for the groundbreaking study, discusses the urgent clinical question driving the trial.

The multi-center Phase III study is challenging standard practice by addressing the uncertainty surrounding Contrast-Associated Acute Kidney Injury (CA-AKI) following peripheral interventions.

The design is innovative: patients are randomised to compare standard iodinated contrast media against the contrast-free approach of CO₂ Angiography. The primary goal is to track Major Adverse Kidney Events at 90 days (MACE-90).

➡️ Watch the video to hear Prof. Steiner’s perspective on the vital need for this definitive data.

📢 Stay Tuned for Part 2! Prof. Steiner will next discuss the trial’s core motivation and discusses as a valid, next-generation alternative.



➡️ Trial ID: NCT06656988

13/10/2025

🎬 A journey through challenges, growth, and everyday dedication — told by those who shaped it.

👉 This is Luca Monti’s story.
Our Clinical & Educational Director and Regional Sales Manager IB LATAM - CANADA.

From being the one to start building the idea with a blank sheet and a pen, to pioneering the clinical path of CO₂​ Angiography in operating rooms across the globe.

His greatest satisfaction? Seeing his team grow and lead the charge in new markets, believing that it’s okay to be afraid and fail, as long as you keep trying and growing together.

His clinical knowledge. His commercial drive.
And the powerful belief that “Alone we go fast, together we go far.”

30/09/2025

17/09/2025

𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐧𝐠 𝐤𝐢𝐝𝐧𝐞𝐲𝐬, 𝐞𝐧𝐬𝐮𝐫𝐢𝐧𝐠 𝐬𝐚𝐟𝐞𝐭𝐲, 𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐚 𝐛𝐞𝐭𝐭𝐞𝐫 𝐚𝐧𝐝 𝐬𝐚𝐟𝐞𝐫 𝐟𝐮𝐭𝐮𝐫𝐞 𝐟𝐨𝐫 𝐚𝐥𝐥 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬.

On , we reaffirm our mission:
to make every angiographic procedure safer, accessible to all patients, and kidney-friendly.

Because behind every procedure, it’s not just a clinical case — it’s a patient, a story, a life.

05/09/2025

🔍The Silent Power of Precision.

They don’t work on the product itself — they make sure everything around it is solid, certified, and trusted. From audits to certifications, from internal processes to international approvals, their work is what allows innovation to reach patients safely.

Invisible on the surface, essential at the core.

This is a glimpse into the world of our Quality & Regulatory Affairs team.
The ones who turn standards into confidence, every day.

🤍

03/09/2025

🔍 They don’t build the product. They build the trust behind it.
The ones who make sure that every detail, every process, every document stands up to the highest standards — every single time.

In the complex world of medical devices, compliance isn’t a checkbox.
It’s a daily mission. A shared responsibility.
A quiet and rigorous force that keeps everything and everyone aligned, safe, and ready.

From quality control to regulatory affairs, from certifications to audits, from internal processes to global approvals, they connect the inside to the outside, making sure our work speaks the language of reliability.

🧩 This is our Quality & Regulatory team.
They don’t just follow the rules — they uphold the meaning behind them.